Regeneron registers two new trials: prion disease gene therapy and HS/obesity combo drugSep 22Weekly roundup, 2 itemsALN-6457olatorepatide
Regeneron's Phase 2 olatorepatide obesity trial recruiting across five U.S. sitesJul 6Trial updateolatorepatideRegeneron Pharmaceuticals
Sign inSign in